Table 2.
Correlation Between the Variables and NAFLD in Patients with SCZ
| Variables | n | r | P | 95% CI |
|---|---|---|---|---|
| Sex | 310 | 0.047 | 0.404 | 0.524−1.298 |
| Marital status | 310 | 0.108 | 0.161 | −0.013−0.207 |
| Hypertension | 310 | 0.159 | 0.005 | 1.283−4.393 |
| Diabetes | 310 | 0.208 | <0.001 | 1.812−8.438 |
| APP | 310 | 0.131 | 0.021 | 1.084−2.722 |
| Age | 310 | 0.001 | 0.989 | −0.103−0.108 |
| BMI | 310 | 0.596 | <0.001 | 0.506−0.667 |
| Duration of SCZ | 310 | 0.038 | 0.507 | −0.073−0.163 |
| Years of education | 310 | −0.031 | 0.586 | −0.142−0.081 |
| BPRS score | 310 | −0.034 | 0.547 | −0.148−0.081 |
| Affinity | 310 | −0.041 | 0.477 | −0.160−0.080 |
| Negative symptoms | 310 | −0.016 | 0.784 | −0.074−0.169 |
| Positive symptoms | 310 | −0.025 | 0.655 | −0.136−0.097 |
| Activation | 310 | 0.032 | 0.569 | −0.081−0.147 |
| Resistance | 310 | −0.069 | 0.226 | −0.180−0.056 |
| Drug doses | 310 | −0.014 | 0.807 | −0.133−0.107 |
| ALT | 310 | 0.321 | <0.001 | 0.0.223−0.417 |
| AST | 310 | 0.182 | 0.001 | 0.065−0.285 |
| ALP | 310 | −0.060 | 0.291 | −0.166−0.059 |
| GGT | 310 | 0.256 | <0.001 | 0.152−0.365 |
| TC | 310 | 0.181 | 0.001 | 0.067−0.295 |
| HDL | 310 | −0.110 | 0.053 | −0.215−-0.014 |
| TG | 310 | 0.342 | <0.001 | 0.227−0.447 |
| ApoA1 | 310 | −0.057 | 0.317 | −0.174−0.055 |
| ApoB | 310 | 0.356 | <0.001 | 0.247−0.449 |
| Creatinine | 310 | 0.006 | 0.915 | −0.088−0.112 |
| UA | 310 | 0.286 | <0.001 | 0.177−0.390 |
| Blood glucose | 310 | 0.201 | <0.001 | 0.101−0.318 |
| NLR | 310 | −0.093 | 0.101 | −0.209−0.020 |
| MLR | 310 | −0.101 | 0.077 | −0.206−0.014 |
| PLR | 310 | −0.119 | 0.036 | −0.234−-0.001 |
Notes: Value of Cramer’s V was used to evaluate the correlations between categorical variables and NAFLD; Spearman’s rank correlation coefficients were used to evaluate the correlations between continuous variables and NAFLD; Statistically significant P−values are shown in bold.
Abbreviations: APP, antipsychotic polypharmacy; BMI, body mass index; BPRS, Brief Psychiatric Rating Scale (BPRS) scores; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; TG, triglycerides; ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; UA, uric acid; PLR, platelet-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; NAFLD, non-alcoholic fatty liver disease; SCZ, schizophrenia; CI, confidence interval.